ArticlebioRxiv : the preprint server for biology2024
Cell-based high-content approach for SARS-CoV-2 neutralization identifies unique monoclonal antibodies and PI3K pathway inhibitors.
Carly R Cabel et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.